Autism spectrum disorders

Annals of Saudi Medicine

Volumn 30, Issue 4, 2010, Pages 295-300

  Faras, Hadeel ^a   Al Ateeqi, Nahed ^a   Tidmarsh, Lee ^b  

^a AL SABAH HOSPITAL   (Kuwait)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; MEASLES MUMPS RUBELLA VACCINE; THIOMERSAL;

AUTISM; CHELATION THERAPY; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIET SUPPLEMENTATION; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; HYPERBARIC OXYGEN; MEDICAL INFORMATION; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; ADOLESCENT; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; HUMANS; PREVALENCE; SEVERITY OF ILLNESS INDEX;

EID: 77955010973     PISSN: 02564947     EISSN: 09754466     Source Type: Journal    
DOI: 10.4103/0256-4947.65261     Document Type: Review

References (60)

1. Kolvin I. Studies in childhood psychoses: I. Diagnostic criteria and classification. Brit J Psychiatry 1971;118:381-384
2. Klin A. Asperger syndrome: an update. Rev Bras Psiquiatr 2003;25:103-109
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Arlington, VA: American Psychiatric Publishing, Inc; 2000. p. 69-84.
4. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th Revision. World Health Organization; 2007 Available from: http://www.who.int/classifications/apps/icd/icd10online/. [last cited on 2009 Mar 19].
5. Mattila ML, Kielinen M, Jussila K, Linna SL, Bloigu R, Ebeling H, Moilanen I. An epidemiological and diagnostic study of Asperger syndrome according to four sets of diagnostic criteria. J Am Acad Child Adolesc Psychiatry 2007;46:636-646
6. McAlonan GM, Suckling J, Wong N, Cheung V, Lienenkaemper N, Cheung C, et al. Distinct patterns of grey matter abnormality in high-functioning autism and Asperger's syndrome. J Child Psychol Psychiatry 2008;49:1287-1295
7. Fombonne E, Zakarian R, Bennett A, Meng L, McLean-Heywood D. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations. Pediatrics 2006;118:e139-50. Available from: http://pediatrics. aappublications.org/cgi/reprint/118/1/e139. [last cited on 2009 Jun 19].
8. Chakrabarti S, Fombonne E. Pervasive developmental disorders in preschool children. JAMA 2001;285:3093-3099
9. Chakrabarti S, Fombonne E. Pervasive developmental disorders in preschool children: confirmation of high prevalence. Am J Psychiatry 2005;162:1133-1141
10. Centers for Disease Control and Prevention. Mental health in the United States: parental report of diagnosed autism in children aged 4-17 years, United States, 2003-2004. MMWR Morb Mortal Wkly Rep 2006;55:481-486 Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5517a3.htm. [last cited on 2009 Mar 19].
11. Bertrand J, Mars A, Boyle C, Bove F, Yeargin-Allsop M, DeCoufle P. Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation. Pediatr 2001;108:1155-1161
12. Yeargin-Allsopp M, Rice C, Karapurkar T, Doernberg N, Boyle C, Murphy C. Prevalence of autism in a US metropolitan area. JAMA 2003;289:49-55.
13. Shattuck PT. The contribution of diagnostic substitution to the growing administrative prevalence of autism in US special education data. Pediatr 2006;117:1028-1037
14. Bailey A, Le Couteur A, Gottesman, Bolton P, Simonoff E, Yuzda E, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995;25:63-77.
15. Marco EJ, Skuse DH. Autism-lessons from the X chromosome. Soc Cogn Affect Neurosci 2006;1:183-193
16. Kothur K, Ray M, Malhi P. Correlation of autism with temporal tubers in tuberous sclerosis complex. Neurol India 2008;56:74-76
17. Muhle R, Trentacoste SV, Rapin I. The genetics of autism. Pediatrics 2004;113:e472-86. Available from: http://www.pediatrics.aappublications.org/cgi/ reprint/113/5/e472. [last cited on 2009 Jun 19].
18. Bolton PF, Park RJ, Higgins JN, Griffiths PD, Pickles A. Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain 2002;125:1247-1255
19. Trottier G, Srivastava L, Walker CD. Etiology of infantile autism: a review of recent advances in genetic and neurobiological research. J Psychiatry Neurosci 1999;24:103-115
20. Steiner CE, Acosta AX, Guerreiro MM, Marques-de-Faria AP. Genotype and natural history in unrelated individuals with phenylketonuria and autistic behavior. Arq Neuropsiquiatr 2007;65:202-205 Available from: http://www.scielo.br/scielo.php?script=sci-arttextandpid=S0004- 282X2007000200003andlng=enandnrm=isoandtlng=en. [last cited on 2009 Jun 19].
21. Levy SE, Hyman SL. Complementary and alternative medicine treatments for children with autism spectrum disorders. Child Adolesc Psychiatr Clin N Am 2008;17:803-820
22. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, et al. Ileal-lymphoid-nodular hyperplasia, non-specific colitis and pervasive developmental disorder in children. Lancet 1998;351:637-641
23. Jansen VA, Stollenwerk N, Jensen HJ, Ram say ME, Edmunds WJ, Rhodes CJ. Measles outbreaks in a population with declining vaccine uptake. Science 2003;301:804.
24. Kaye JA, del Mar Melero-Montes M, Jick H. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ 2001;322:460-463
25. Madsen KM, Hviid A, Vestergaard M, Wohlfahrt J, Thorsen P, Olsen J, et al. A population-based study of measles, mumps and rubella vaccination and autism. N Engl J Med 2002;347:1477-1482 (Pubitemid 35257586)
26. Dales L, Hammer SJ, Smith NJ. Time trends in autism and in MMR immunization coverage in California. JAMA 2001;285:1183-1185
27. Taylor B, Miller E, Lingam R, Andrews N, Simmons A, Stowe J. Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ 2002;324:393-396
28. Institute of Medicine of National Academies [Internet]. Immunization Safety Review: Vaccines and Autism. Institute of Medicine of National Academies: Immunization safety review committee. Academies 2004. Available from: http://www.iom.edu/CMS/3793/4705/20155.aspx. [last cited on 2009 Jun 20].
29. DeStefano F, Bhasin TK, Thompson WW, Yeargin-Allsopp M, Boyle C. Age at first measles-mumps-rubella vaccination in children with autism and school-matched control subjects: a population-based study in metropolitan Atlanta. Pediatr 2004;113:259-266
30. Infectious Diseases and Immunization Committee, Canadian Paediatric Society. Autistic spectrum disorder: No causal relationship with vaccines. Paediatr Child Health 2007;12:393-395 Available from: http://www.pubmedcentral. nih.gov/picrender.fcgi?artid=2528717andblobtype=pdf. [last cited on 2009 Jun 20].
31. Hviid A, Stellfeld M, Wohlfahrt J, Melbye M. Association between thimerosal-containing vaccine and autism. JAMA 2003;290:1763-1766
32. Andrews N, Miller E, Grant A, Stowe J, Osborne V, Taylor B. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United Kingdom does not support a causal association. Pediatrics 2004;114:584-591
33. Madsen KM, Lauritsen MB, Pedersen CB, Thorsen P, Plesner AM, Andersen PH, et al. Thimerosal and the occurrence of autism: Negative ecological evidence from Danish population-based data. Pediatrics 2003;112:604-606
34. Parker SK, Schwartz B, Todd J, Pickering LK. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics 2004;114:793-804.
35. Johnson CP, Myers SM; American Academy of Pediatrics Council on Children With Disabilities. Identification and evaluation of children with autism spectrum disorders. Pediatrics 2007;120:1183-1215
36. Risi S, Lord C, Gotham K, Corsello C, Chrysler C, Szatmari P, et al. Combining information from multiple sources in the diagnosis of autism spectrum disorders. J Am Acad Child Adolesc Psychiatry 2006;45:1094-1103
37. Baron-Cohen S, Wheelwright S, Cox A, Baird G, Charman T, Swettenham J, et al. Early identification of autism by the CHecklist for Autism in Toddlers (CHAT). J R Soc Med 2000;93:521-525
38. Wong V, Hui LH, Lee WC, Leung LS, Ho PK, Lau WL, et al. A modified screening tool for autism (Checklist for Autism in Toddlers [CHAT-23]) for Chinese children. Pediatrics 2004;114:e166-76. Available from: http://www.pediatrics.aappublications.org/cgi/reprint/114/2/e166. [last cited on 2009 Jun 19].
39. Pereira A, Riesgo RS, Wagner MB. Childhood autism: translation and validation of the childhood autism rating scale for use in Brazil. J Pediatr (Rio J) 2008;84:487-494 Available from: http://www.jped.com.br/conteudo/08-84- 06-487/ing.pdf. [last cited on 2009 Jun 20].
40. Charman T, Baird G, Simonoff E, Loucas T, Chandler S, Meldrum D, Pickles A. Efficacy of three screening instruments in the identification of autistic-spectrum disorders. Br J Psychiatry 2007;191:554-559
41. Rutter M, Le Couteur A, Lord C. Autism Diagnostic Interview-Revised. Los Angeles: Western Psychological Services; 2003.
42. Lord C, Risi S, Lambrecht L, Leventhal BL, DiLavore PC, Pickles A, et al. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 2000;30:205-223
43. Akshoomoff N, Corsello C, Schmidt H. The Role of the Autism Diagnostic Observation Schedule in the Assessment of Autism Spectrum Disorders in School and Community Settings. Calif School Psychol 2006;11:7-19.
44. Barton M, Volkmar F. How commonly are known medical conditions associated with autism? J Autism Dev Disord 1998;28:273-278
45. Scottish Intercollegiate Guidelines Network (SIGN) 98. Assessment, diagnosis and clinical intervention for children and young people with autism spectrum disorders. A nation clinical guideline. 2007 July Available from: http://www.sign.ac.uk/pdf/sign98.pdf. [last cited on 2009 Jun 19].
46. Filipek PA, Accardo PJ, Baranek GT, Cook EH Jr, Dawson G, Gordon B, et al. The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord 1999;29:439-484
47. McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med 2002;347:314-321
48. Canitano R, Scandurra V. Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents. Neuropsychiatr Dis Treat 2008;4:723-730
49. Barbaresi WJ, Katusic SK, Voigt RG. Autism: a review of the state of the science for pediatric primary health care clinicians. Arch Pediatr Adolesc Med 2006;160:1167-1175
50. Ospina MB, Krebs Seida J, Clark B, Karkhaneh M, Hartling L, Tjosvold L, et al. Behavioural and developmental interventions for autism spectrum disorder: a clinical systematic review. PLoS One. 2008;3:e3755. Available from: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2582449andblobtype=pdf. [last cited on 2009 Jun 19].
51. Ooi YP, Lam CM, Sung M, Tan WT, Goh TJ, Fung DS, et al. Effects of cognitive-behavioural therapy on anxiety for children with high-functioning autistic spectrum disorders. Singapore Med J 2008;49:215-220
52. Couper JJ, Sampson AJ. Children with autism deserve evidence-based intervention. Med J Aust 2003;178:424-425
53. Williams White S, Keonig K, Scahill L. Social skills development in children with autism spectrum disorders: a review of the intervention research. J Autism Dev Disord 2007;37:1858-1868
54. Sallows GO, Graupner TD. Intensive behavioral treatment for children with autism: four-year outcome and predictors. Am J Ment Retard 2005;110:417-438
55. Nye C, Brice A. Combined vitamin B6-magnesium treatment in autism spectrum disorder. Cochrane Database Syst Rev 2005;4:CD003497. Available from: http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003497/frame. html. [last cited on 2009 Jun 19].
56. Millward C, Ferriter M, Calver SJ, Connell-Jones GG. Gluten- and casein-free diets for autistic spectrum disorder. Cochrane Database Syst Rev 2008;2:CD003498. Available from: http://www.mrw.interscience.wiley.com/cochrane/ clsysrev/articles/CD003498/frame.html. [last cited on 2009 Jun 19].
57. Baxter AJ, Krenzelok EP. Pediatric fatality secondary to EDTA chelation. Clin Toxicol 2008;46:1083-1084
58. Rossignol DA, Rossignol LW, James SJ, Melnyk S, Mumper E. The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot study. BMC Pediatr 2007;7:36.
59. Chungpaibulpatana J, Sumpatanarax T, Thadakul N, Chantharatreerat C, Konkaew M, Aroonlimsawas M. Hyperbaric oxygen therapy in Thai autistic children. J Med Assoc Thai 2008;91:1232-1238
60. Rossignol DA, Rossignol LW, Smith S, Schneider C, Logerquist S, Usman A, et al. Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial. BMC Pediatr 2009;13:9:21. Available from: http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=2662857andblobtype=pdf. [last cited on 2009 Jun 19].